MAPT and supranuclear palsy, progressive, 1: The expression level of substrates can amplify the pathogenic seed and contribute to the selected vulnerability of different neuronal populations24,25, and we previously showed higher concentrations of tau protein and higher levels of 4R tau transcripts in skin lysates of PSP and CBD vs synucleinopathies and HC22.